937 related articles for article (PubMed ID: 11429225)
41. Treatment of early and intermediate stages of supradiaphragmatic Hodgkin's disease: the Swedish National Care Programme experience. Swedish Lymphoma Study Group.
Glimelius B; Kälkner M; Enblad G; Gustavsson A; Jakobsson M; Branehög I; Lenner P
Ann Oncol; 1994 Nov; 5(9):809-16. PubMed ID: 7848883
[TBL] [Abstract][Full Text] [Related]
42. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
[TBL] [Abstract][Full Text] [Related]
43. Hodgkin's disease in Hong Kong Chinese.
Liang R; Choi P; Todd D; Chan TK; Choy D; Ho F
Hematol Oncol; 1989; 7(6):395-403. PubMed ID: 2807177
[TBL] [Abstract][Full Text] [Related]
44. Hodgkin's disease stage I and II. A comparison between two different treatment policies.
Stoffel TJ; Cox JD
Cancer; 1977 Jul; 40(1):90-7. PubMed ID: 406982
[TBL] [Abstract][Full Text] [Related]
45. Cure of early-stage Hodgkin's disease with subtotal nodal irradiation.
Wasserman TH; Trenkner DA; Fineberg B; Kucik N
Cancer; 1991 Sep; 68(6):1208-15. PubMed ID: 1873772
[TBL] [Abstract][Full Text] [Related]
46. Follow-up of pathological stage I and IIA supradiaphragmatic Hodgkin's disease primarily treated with radiotherapy.
Banfi A; Zanini M; Zucali R; Ricci SB; Lattuada A; Milani F; Rizzato R; Volterrani F
Tumori; 1982 Aug; 68(4):313-20. PubMed ID: 7147356
[TBL] [Abstract][Full Text] [Related]
47. The management of stage I-II supradiaphragmatic Hodgkin's disease with chemotherapy alone.
Provencio M; España P; Millán I; Sánchez A; Cantos B; Bonilla F
Leuk Lymphoma; 2003 Feb; 44(2):263-8. PubMed ID: 12688343
[TBL] [Abstract][Full Text] [Related]
48. Prognostic factors in patients with subdiaphragmatic Hodgkin's disease.
Mauch P; Greenberg H; Lewin A; Cassady JR; Weichselbaum R; Hellman S
Hematol Oncol; 1983; 1(3):205-14. PubMed ID: 6677563
[TBL] [Abstract][Full Text] [Related]
49. Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
Leslie NT; Mauch PM; Hellman S
Cancer; 1985 May; 55(9 Suppl):2072-8. PubMed ID: 3919921
[TBL] [Abstract][Full Text] [Related]
50. Histopathologic grading of nodular sclerosis Hodgkin's disease. Lack of prognostic significance in 254 surgically staged patients.
Hess JL; Bodis S; Pinkus G; Silver B; Mauch P
Cancer; 1994 Jul; 74(2):708-14. PubMed ID: 8033052
[TBL] [Abstract][Full Text] [Related]
51. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
[TBL] [Abstract][Full Text] [Related]
52. Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie.
Noordijk EM; Carde P; Mandard AM; Mellink WA; Monconduit M; Eghbali H; Tirelli U; Thomas J; Somers R; Dupouy N
Ann Oncol; 1994; 5 Suppl 2():107-12. PubMed ID: 7515643
[TBL] [Abstract][Full Text] [Related]
53. Salvage of relapse of patients with Hodgkin's disease in clinical stages I or II who were staged with laparotomy and initially treated with radiotherapy alone. A report from the international database on Hodgkin's disease.
Specht L; Horwich A; Ashley S
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):805-11. PubMed ID: 7960982
[TBL] [Abstract][Full Text] [Related]
54. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Campbell B; Wirth A; Milner A; Di Iulio J; MacManus M; Ryan G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1538-45. PubMed ID: 16125872
[TBL] [Abstract][Full Text] [Related]
55. Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefit.
Gomez GA; Reese PA; Nava H; Panahon AM; Barcos M; Stutzman L; Han T; Henderson ES
Am J Med; 1984 Aug; 77(2):205-10. PubMed ID: 6380286
[TBL] [Abstract][Full Text] [Related]
56. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
57. Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin's disease?
Goodman RL; Piro AJ; Hellman S
Cancer; 1976 Jun; 37(6):2834-9. PubMed ID: 949703
[TBL] [Abstract][Full Text] [Related]
58. High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party.
Sweetenham JW; Carella AM; Taghipour G; Cunningham D; Marcus R; Della Volpe A; Linch DC; Schmitz N; Goldstone AH
J Clin Oncol; 1999 Oct; 17(10):3101-9. PubMed ID: 10506605
[TBL] [Abstract][Full Text] [Related]
59. Results of treatment of stage 3A Hodgkin's disease.
Willett CG; Linggood RM; Meyer J; Orlow E; Lindfors K; Doppke K; Aisenberg AC
Cancer; 1987 Jan; 59(1):27-30. PubMed ID: 3791147
[TBL] [Abstract][Full Text] [Related]
60. Clinical versus pathologic stage I and II Hodgkin's disease.
Cox JD; Stoffel TJ
Oncology; 1980; 37(5):325-8. PubMed ID: 7443165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
